Opens in a new tab

Powell Gilbert LLP v Abbott Diabetes Care (CFI, 29 July 2024)

Date29 July 2024
CourtCFI
DivisionThe Hague (NL) Local Division
Type of actionApplication RoP262.1 (b)
Registry referenceApp_39789/2024 · ORD_39938/2024
PartiesPowell Gilbert LLP

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 29 July 2024 (UPC_CFI_131/2024, ORD_39938/2024), the judge-rapporteur of The Hague Local Division granted Powell Gilbert LLP, acting as a member of the public under Rule 262.1(b) RoP, access to six written pleadings from the provisional measures proceedings brought by Abbott Diabetes Care against Sibio Technology and Umedwings Netherlands on EP 3 831 283, despite Abbott’s appeal against the order refusing relief. Access will be given only after 15 days, provided no party has appealed, leave to appeal being granted. A separate order to the same effect was made on the same day in the parallel proceedings UPC_CFI_130/2024.

Question

May a member of the public obtain access to the pleadings and evidence of first-instance proceedings that ended with a decision under appeal?

Decision

The judge applies paragraphs 47 to 50 of the Court of Appeal’s order in Ocado v Autostore. The public’s interest in understanding the decision is sufficient, which disposes of Sibio’s objection. The pending appeal does not justify refusal: as the public decision already contains the relevant arguments and evidence, protecting the integrity of the proceedings no longer requires access to be withheld. That some arguments were not addressed at first instance makes no difference. Since no exhibit, Annex E1 included, was filed under Rule 262A RoP and Abbott gave no specific reasons, the objection concerning the annexes is rejected. Leave to appeal is granted, as Rules 220 and 224 RoP and Art. 73 UPCA do not make clear when an appeal may be lodged.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 73
Rules of Procedure
Rules 220, 224, 262.1(b), 262.2 and 262A
Case law cited
Ocado Innovation v Autostore, Court of Appeal, 10 April 2024

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Confidentiality club.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Application RoP262.1 (b)
Outcome (Dhenne Avocats summary)
Powell Gilbert obtient l'accès aux écritures et pièces demandées, quinze jours après la signification et sous réserve d'absence d'appel, l'autorisation d'appel étant accordée.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 831 283
Analyte sensor devices, connections, and methods
recorded proprietor: Abbott Diabetes Care Inc
Mentioned in the analysis (role not qualified)
Also mentioned in 8 other decision(s): Sibio v Abbott Diabetes Care (CoA, 14 August 2026) · Sibio Technology v Abbott Diabetes Care (CFI, 21 July 2025) · Abbott Diabetes Care v Sibio Technology (CFI, UPC_CFI_131/2024, 19 Jun · Sibio v Abbott Diabetes Care (CoA, 27 February 2026) · Abbott Diabetes Care v Sibio (CoA, 14 February 2025) · Abbott Diabetes Care v Powell Gilbert LLP (CoA, 9 January 2025) · Abbott Diabetes Care v Sibio Technology (CoA, 26 July 2024) · Abbott Diabetes Care v Sibio Technology (CFI, UPC_CFI_130/2024, 19 Jun
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.